(주)엘바이오사이언스

{
  "address": "충청남도 아산시",
  "ceo_name": "박상수",
  "certificate": [
    {
      "cert_number": "20230308030021",
      "changes": "",
      "disclosure_date": "2023-03-08",
      "first_cert_date": "2023-03-08",
      "no": "1",
      "type": "혁신성장유형",
      "valid_period": "2023-03-08 ~ 2026-03-07"
    },
    {
      "cert_number": "20260210010016",
      "changes": "",
      "disclosure_date": "2026-02-10",
      "first_cert_date": "2023-03-08",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2026-03-08 ~ 2029-03-07"
    }
  ],
  "company_name": "(주)엘바이오사이언스",
  "corp_no": "164811-*******",
  "financials": {
    "2022": {
      "capital_stock": 3000000000,
      "cost_of_sales": 0,
      "current_assets": 2489165000,
      "current_liabilities": 185348000,
      "gross_profit": 5433000,
      "net_income": -1200278000,
      "net_income_bs": -1200278000,
      "non_current_assets": 339714000,
      "non_current_liabilities": 1015659000,
      "non_operating_expenses": 37627000,
      "non_operating_income": 45259000,
      "operating_profit": -1207910000,
      "revenue": 5433000,
      "sga_expenses": 1213343000,
      "total_assets": 2828879000,
      "total_equity": 1627872000,
      "total_liabilities": 1201007000
    },
    "2023": {
      "capital_stock": 4478000000,
      "cost_of_sales": 0,
      "current_assets": 1174591000,
      "current_liabilities": 16626000,
      "gross_profit": 3883000,
      "net_income": -3230947000,
      "net_income_bs": -3230947000,
      "non_current_assets": 328735000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 126050000,
      "non_operating_income": 83275000,
      "operating_profit": -3188172000,
      "revenue": 3883000,
      "sga_expenses": 3192055000,
      "total_assets": 1503326000,
      "total_equity": 1486700000,
      "total_liabilities": 16626000
    },
    "2024": {
      "capital_stock": 4477999000,
      "cost_of_sales": 0,
      "current_assets": 575321000,
      "current_liabilities": 1151133000,
      "gross_profit": 179761000,
      "net_income": -1609082000,
      "net_income_bs": -1609082000,
      "non_current_assets": 453430000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 24902000,
      "non_operating_income": 30948000,
      "operating_profit": -1615128000,
      "revenue": 179761000,
      "sga_expenses": 1794889000,
      "total_assets": 1028751000,
      "total_equity": -122382000,
      "total_liabilities": 1151133000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "120,000,000",
      "changes": "120,000,000",
      "date": "2025-12-19"
    }
  ],
  "main_products": "현개발중 : 펜터민+토피라메이트 복합제, 알긴산/ 카르복시메틸셀룰로오스나트륨 복합제, 토피라메이트 서방정, 두타스테리드 서방주사제, 대장하제",
  "phone": "041-544-****",
  "years": [
    2024,
    2023,
    2022
  ]
}